| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-44 |
GENE |
denotes |
Sterol regulatory element-binding protein-1c |
| T1 |
0-44 |
GENE |
denotes |
Sterol regulatory element-binding protein-1c |
| T2 |
54-62 |
POSREG |
denotes |
increase |
| T3 |
66-91 |
MPA |
denotes |
postprandial stearic acid |
| T4 |
105-111 |
MPA |
denotes |
target |
| T5 |
116-125 |
POSREG |
denotes |
improving |
| T7 |
126-133 |
GENE |
denotes |
insulin |
| T6 |
126-144 |
MPA |
denotes |
insulin resistance |
| T8 |
149-163 |
MPA |
denotes |
hyperlipidemia |
| T9 |
149-163 |
DISEASE |
denotes |
hyperlipidemia |
| T10 |
165-173 |
POSREG |
denotes |
Elevated |
| T11 |
174-196 |
MPA |
denotes |
serum free fatty acids |
| T12 |
198-202 |
MPA |
denotes |
FFAs |
| T13 |
204-210 |
MPA |
denotes |
levels |
| T14 |
211-215 |
REG |
denotes |
play |
| T15 |
229-233 |
REG |
denotes |
role |
| T17 |
256-263 |
GENE |
denotes |
insulin |
| T16 |
256-274 |
MPA |
denotes |
insulin resistance |
| T18 |
276-278 |
MPA |
denotes |
IR |
| T19 |
284-292 |
DISEASE |
denotes |
diabetes |
| T20 |
386-397 |
MPA |
denotes |
FFA profile |
| T21 |
401-415 |
MPA |
denotes |
hyperlipidemia |
| T22 |
401-415 |
DISEASE |
denotes |
hyperlipidemia |
| T23 |
417-420 |
MPA |
denotes |
HLP |
| T24 |
432-440 |
REG |
denotes |
relation |
| T26 |
446-453 |
GENE |
denotes |
insulin |
| T25 |
446-465 |
MPA |
denotes |
insulin sensitivity |
| T27 |
505-523 |
MPA |
denotes |
serum stearic acid |
| T28 |
525-527 |
MPA |
denotes |
SA |
| T29 |
541-551 |
MPA |
denotes |
fatty acid |
| T30 |
560-569 |
POSREG |
denotes |
increased |
| T31 |
590-602 |
MPA |
denotes |
postprandial |
| T32 |
614-623 |
POSREG |
denotes |
elevation |
| T33 |
627-629 |
MPA |
denotes |
SA |
| T34 |
633-636 |
REG |
denotes |
due |
| T35 |
640-649 |
POSREG |
denotes |
increased |
| T37 |
650-668 |
GENE |
denotes |
insulin-stimulated |
| T36 |
650-686 |
MPA |
denotes |
insulin-stimulated de novo synthesis |
| T38 |
687-695 |
REG |
denotes |
mediated |
| T39 |
699-743 |
GENE |
denotes |
sterol regulatory element-binding protein-1c |
| T40 |
744-765 |
GENE |
denotes |
(SREBP-1c)/acetyl-CoA |
| T41 |
744-765 |
GENE |
denotes |
(SREBP-1c)/acetyl-CoA |
| T42 |
766-808 |
GENE |
denotes |
carboxylase/fatty acid synthase/elongation |
| T43 |
784-808 |
GENE |
denotes |
acid synthase/elongation |
| T44 |
851-857 |
GENE |
denotes |
ELOVL6 |
| T45 |
851-857 |
GENE |
denotes |
ELOVL6 |
| T46 |
867-877 |
POSREG |
denotes |
elongation |
| T47 |
881-894 |
MPA |
denotes |
palmitic acid |
| T48 |
896-898 |
MPA |
denotes |
PA |
| T49 |
900-909 |
REG |
denotes |
catalyzed |
| T50 |
913-919 |
GENE |
denotes |
ELOVL6 |
| T51 |
913-919 |
GENE |
denotes |
ELOVL6 |
| T52 |
921-935 |
NEGREG |
denotes |
Downregulation |
| T53 |
939-947 |
GENE |
denotes |
SREBP-1c |
| T54 |
951-957 |
GENE |
denotes |
ELOVL6 |
| T55 |
961-982 |
MPA |
denotes |
small interfering RNA |
| T56 |
987-993 |
NEGREG |
denotes |
reduce |
| T57 |
994-1006 |
MPA |
denotes |
SA synthesis |
| T58 |
1020-1034 |
MPA |
denotes |
serum SA level |
| T59 |
1048-1060 |
POSREG |
denotes |
amelioration |
| T60 |
1064-1066 |
MPA |
denotes |
IR |
| T61 |
1070-1073 |
MPA |
denotes |
HLP |
| T62 |
1089-1099 |
NEGREG |
denotes |
inhibition |
| T63 |
1103-1111 |
GENE |
denotes |
SREBP-1c |
| T64 |
1133-1142 |
POSREG |
denotes |
improving |
| T65 |
1143-1145 |
MPA |
denotes |
IR |
| T66 |
1151-1162 |
NEGREG |
denotes |
suppression |
| T67 |
1166-1172 |
GENE |
denotes |
ELOVL6 |
| T68 |
1192-1204 |
POSREG |
denotes |
accumulation |
| T69 |
1208-1210 |
MPA |
denotes |
PA |
| T70 |
1224-1233 |
POSREG |
denotes |
increased |
| T71 |
1234-1249 |
MPA |
denotes |
postprandial SA |
| T72 |
1253-1259 |
REG |
denotes |
caused |
| T73 |
1267-1285 |
POSREG |
denotes |
insulin-stimulated |
| T74 |
1267-1285 |
GENE |
denotes |
insulin-stimulated |
| T75 |
1286-1294 |
GENE |
denotes |
SREBP-1c |
| T76 |
1286-1294 |
GENE |
denotes |
SREBP-1c |
| T77 |
1295-1302 |
MPA |
denotes |
pathway |
| T78 |
1307-1317 |
POSREG |
denotes |
elongation |
| T79 |
1321-1323 |
MPA |
denotes |
PA |
| T80 |
1327-1330 |
MPA |
denotes |
HLP |
| T81 |
1332-1341 |
NEGREG |
denotes |
Reduction |
| T82 |
1345-1360 |
MPA |
denotes |
postprandial SA |
| T83 |
1371-1380 |
MPA |
denotes |
candidate |
| T84 |
1385-1394 |
POSREG |
denotes |
improving |
| T85 |
1395-1397 |
MPA |
denotes |
IR |
| T86 |
1403-1411 |
GENE |
denotes |
SREBP-1c |
| T87 |
1403-1411 |
GENE |
denotes |
SREBP-1c |
| T88 |
1436-1442 |
MPA |
denotes |
target |
| T89 |
1454-1456 |
MPA |
denotes |
IR |
| T90 |
1461-1469 |
DISEASE |
denotes |
diabetes |
| T91 |
1473-1483 |
NEGREG |
denotes |
decreasing |
| T92 |
1484-1486 |
MPA |
denotes |
SA |
| R0 |
T0 |
T2 |
CauseOf |
Sterol regulatory element-binding protein-1c,increase |
| R1 |
T0 |
T5 |
CauseOf |
Sterol regulatory element-binding protein-1c,improving |
| R10 |
T8 |
T4 |
ThemeOf |
hyperlipidemia,target |
| R100 |
T66 |
T68 |
CauseOf |
suppression,accumulation |
| R101 |
T67 |
T66 |
ThemeOf |
ELOVL6,suppression |
| R102 |
T69 |
T68 |
ThemeOf |
PA,accumulation |
| R103 |
T70 |
T72 |
CauseOf |
increased,caused |
| R104 |
T70 |
T78 |
CauseOf |
increased,elongation |
| R105 |
T71 |
T70 |
ThemeOf |
postprandial SA,increased |
| R106 |
T71 |
T72 |
ThemeOf |
postprandial SA,caused |
| R107 |
T73 |
T70 |
CauseOf |
insulin-stimulated,increased |
| R108 |
T73 |
T72 |
CauseOf |
insulin-stimulated,caused |
| R109 |
T77 |
T73 |
ThemeOf |
pathway,insulin-stimulated |
| R11 |
T8 |
T5 |
ThemeOf |
hyperlipidemia,improving |
| R110 |
T73 |
T78 |
CauseOf |
insulin-stimulated,elongation |
| R111 |
T75 |
T73 |
ThemeOf |
SREBP-1c,insulin-stimulated |
| R112 |
T75 |
T77 |
ThemeOf |
SREBP-1c,pathway |
| R113 |
T78 |
T72 |
CauseOf |
elongation,caused |
| R114 |
T79 |
T78 |
ThemeOf |
PA,elongation |
| R115 |
T80 |
T79 |
ThemeOf |
HLP,PA |
| R116 |
T80 |
T72 |
ThemeOf |
HLP,caused |
| R117 |
T80 |
T73 |
ThemeOf |
HLP,insulin-stimulated |
| R118 |
T80 |
T78 |
ThemeOf |
HLP,elongation |
| R119 |
T81 |
T84 |
CauseOf |
Reduction,improving |
| R12 |
T10 |
T14 |
CauseOf |
Elevated,play |
| R120 |
T91 |
T81 |
CauseOf |
decreasing,Reduction |
| R121 |
T82 |
T81 |
ThemeOf |
postprandial SA,Reduction |
| R122 |
T82 |
T83 |
ThemeOf |
postprandial SA,candidate |
| R123 |
T82 |
T84 |
ThemeOf |
postprandial SA,improving |
| R124 |
T83 |
T84 |
CauseOf |
candidate,improving |
| R125 |
T91 |
T84 |
CauseOf |
decreasing,improving |
| R126 |
T85 |
T84 |
ThemeOf |
IR,improving |
| R127 |
T85 |
T88 |
ThemeOf |
IR,target |
| R128 |
T86 |
T88 |
ThemeOf |
SREBP-1c,target |
| R129 |
T88 |
T84 |
CauseOf |
target,improving |
| R13 |
T10 |
T15 |
CauseOf |
Elevated,role |
| R130 |
T89 |
T88 |
ThemeOf |
IR,target |
| R131 |
T89 |
T91 |
ThemeOf |
IR,decreasing |
| R132 |
T90 |
T81 |
ThemeOf |
diabetes,Reduction |
| R133 |
T90 |
T84 |
ThemeOf |
diabetes,improving |
| R134 |
T90 |
T88 |
ThemeOf |
diabetes,target |
| R135 |
T90 |
T91 |
ThemeOf |
diabetes,decreasing |
| R136 |
T92 |
T91 |
ThemeOf |
SA,decreasing |
| R14 |
T11 |
T10 |
ThemeOf |
serum free fatty acids,Elevated |
| R15 |
T11 |
T13 |
ThemeOf |
serum free fatty acids,levels |
| R16 |
T11 |
T14 |
ThemeOf |
serum free fatty acids,play |
| R17 |
T12 |
T10 |
ThemeOf |
FFAs,Elevated |
| R18 |
T12 |
T13 |
ThemeOf |
FFAs,levels |
| R19 |
T12 |
T14 |
ThemeOf |
FFAs,play |
| R2 |
T2 |
T5 |
CauseOf |
increase,improving |
| R20 |
T13 |
T10 |
ThemeOf |
levels,Elevated |
| R21 |
T13 |
T14 |
ThemeOf |
levels,play |
| R22 |
T13 |
T15 |
ThemeOf |
levels,role |
| R23 |
T16 |
T14 |
ThemeOf |
insulin resistance,play |
| R24 |
T16 |
T15 |
ThemeOf |
insulin resistance,role |
| R25 |
T16 |
T18 |
ThemeOf |
insulin resistance,IR |
| R26 |
T18 |
T14 |
ThemeOf |
IR,play |
| R27 |
T18 |
T15 |
ThemeOf |
IR,role |
| R28 |
T19 |
T14 |
ThemeOf |
diabetes,play |
| R29 |
T19 |
T15 |
ThemeOf |
diabetes,role |
| R3 |
T3 |
T2 |
ThemeOf |
postprandial stearic acid,increase |
| R30 |
T19 |
T16 |
ThemeOf |
diabetes,insulin resistance |
| R31 |
T21 |
T20 |
ThemeOf |
hyperlipidemia,FFA profile |
| R32 |
T23 |
T20 |
ThemeOf |
HLP,FFA profile |
| R33 |
T20 |
T24 |
ThemeOf |
FFA profile,relation |
| R34 |
T21 |
T23 |
ThemeOf |
hyperlipidemia,HLP |
| R35 |
T21 |
T24 |
ThemeOf |
hyperlipidemia,relation |
| R36 |
T23 |
T24 |
ThemeOf |
HLP,relation |
| R37 |
T25 |
T24 |
ThemeOf |
insulin sensitivity,relation |
| R38 |
T27 |
T28 |
ThemeOf |
serum stearic acid,SA |
| R39 |
T27 |
T29 |
ThemeOf |
serum stearic acid,fatty acid |
| R4 |
T3 |
T4 |
ThemeOf |
postprandial stearic acid,target |
| R40 |
T27 |
T30 |
ThemeOf |
serum stearic acid,increased |
| R41 |
T28 |
T29 |
ThemeOf |
SA,fatty acid |
| R42 |
T28 |
T30 |
ThemeOf |
SA,increased |
| R43 |
T29 |
T30 |
ThemeOf |
fatty acid,increased |
| R44 |
T31 |
T30 |
ThemeOf |
postprandial,increased |
| R45 |
T32 |
T34 |
ThemeOf |
elevation,due |
| R46 |
T32 |
T35 |
CauseOf |
elevation,increased |
| R47 |
T32 |
T46 |
CauseOf |
elevation,elongation |
| R48 |
T33 |
T32 |
ThemeOf |
SA,elevation |
| R49 |
T33 |
T34 |
ThemeOf |
SA,due |
| R5 |
T4 |
T2 |
ThemeOf |
target,increase |
| R50 |
T33 |
T35 |
CauseOf |
SA,increased |
| R51 |
T35 |
T34 |
CauseOf |
increased,due |
| R52 |
T35 |
T38 |
CauseOf |
increased,mediated |
| R53 |
T35 |
T46 |
CauseOf |
increased,elongation |
| R54 |
T36 |
T35 |
ThemeOf |
insulin-stimulated de novo synthesis,increased |
| R55 |
T36 |
T38 |
ThemeOf |
insulin-stimulated de novo synthesis,mediated |
| R56 |
T40 |
T32 |
CauseOf |
(SREBP-1c)/acetyl-CoA,elevation |
| R57 |
T40 |
T35 |
CauseOf |
(SREBP-1c)/acetyl-CoA,increased |
| R58 |
T40 |
T38 |
ThemeOf |
(SREBP-1c)/acetyl-CoA,mediated |
| R59 |
T40 |
T46 |
CauseOf |
(SREBP-1c)/acetyl-CoA,elongation |
| R6 |
T4 |
T5 |
CauseOf |
target,improving |
| R60 |
T43 |
T32 |
CauseOf |
acid synthase/elongation,elevation |
| R61 |
T43 |
T35 |
CauseOf |
acid synthase/elongation,increased |
| R62 |
T43 |
T38 |
ThemeOf |
acid synthase/elongation,mediated |
| R63 |
T43 |
T46 |
CauseOf |
acid synthase/elongation,elongation |
| R64 |
T44 |
T32 |
CauseOf |
ELOVL6,elevation |
| R65 |
T44 |
T35 |
CauseOf |
ELOVL6,increased |
| R66 |
T44 |
T38 |
ThemeOf |
ELOVL6,mediated |
| R67 |
T44 |
T46 |
CauseOf |
ELOVL6,elongation |
| R68 |
T47 |
T38 |
ThemeOf |
palmitic acid,mediated |
| R69 |
T47 |
T46 |
ThemeOf |
palmitic acid,elongation |
| R7 |
T6 |
T4 |
ThemeOf |
insulin resistance,target |
| R70 |
T47 |
T49 |
ThemeOf |
palmitic acid,catalyzed |
| R71 |
T48 |
T38 |
ThemeOf |
PA,mediated |
| R72 |
T48 |
T46 |
ThemeOf |
PA,elongation |
| R73 |
T48 |
T49 |
ThemeOf |
PA,catalyzed |
| R74 |
T50 |
T46 |
CauseOf |
ELOVL6,elongation |
| R75 |
T50 |
T49 |
ThemeOf |
ELOVL6,catalyzed |
| R76 |
T52 |
T35 |
CauseOf |
Downregulation,increased |
| R77 |
T52 |
T46 |
CauseOf |
Downregulation,elongation |
| R78 |
T52 |
T56 |
CauseOf |
Downregulation,reduce |
| R79 |
T52 |
T59 |
CauseOf |
Downregulation,amelioration |
| R8 |
T6 |
T5 |
ThemeOf |
insulin resistance,improving |
| R80 |
T53 |
T52 |
ThemeOf |
SREBP-1c,Downregulation |
| R81 |
T53 |
T55 |
ThemeOf |
SREBP-1c,small interfering RNA |
| R82 |
T54 |
T52 |
ThemeOf |
ELOVL6,Downregulation |
| R83 |
T55 |
T52 |
CauseOf |
small interfering RNA,Downregulation |
| R84 |
T55 |
T56 |
CauseOf |
small interfering RNA,reduce |
| R85 |
T55 |
T59 |
CauseOf |
small interfering RNA,amelioration |
| R86 |
T56 |
T59 |
CauseOf |
reduce,amelioration |
| R87 |
T57 |
T56 |
ThemeOf |
SA synthesis,reduce |
| R88 |
T58 |
T56 |
ThemeOf |
serum SA level,reduce |
| R89 |
T60 |
T59 |
ThemeOf |
IR,amelioration |
| R9 |
T8 |
T2 |
ThemeOf |
hyperlipidemia,increase |
| R90 |
T61 |
T60 |
ThemeOf |
HLP,IR |
| R91 |
T61 |
T59 |
ThemeOf |
HLP,amelioration |
| R92 |
T62 |
T59 |
CauseOf |
inhibition,amelioration |
| R93 |
T62 |
T64 |
CauseOf |
inhibition,improving |
| R94 |
T62 |
T66 |
CauseOf |
inhibition,suppression |
| R95 |
T62 |
T68 |
CauseOf |
inhibition,accumulation |
| R96 |
T63 |
T62 |
ThemeOf |
SREBP-1c,inhibition |
| R97 |
T64 |
T68 |
CauseOf |
improving,accumulation |
| R98 |
T65 |
T64 |
ThemeOf |
IR,improving |
| R99 |
T66 |
T64 |
CauseOf |
suppression,improving |
